This person is not a real SYMTUZA® patient.
Proven tolerability.
You deserve an HIV treatment you can stick with, so talk with your doctor to see if SYMTUZA® is right for you.
A closer look at tolerability.
The tolerability of SYMTUZA® has been studied across 2 clinical trials.
Clinical trial information:
Over 1,100 people living with HIV were treated with SYMTUZA® in the trials.
People new to HIV treatment and people switching HIV treatments were a part of the trials.
Over 1,100 people living with HIV were treated with SYMTUZA® in the trials.
People new to HIV treatment and people switching HIV treatments were a part of the trials.
Clinical trial results:
NO MORE THAN
2%
of patients in any of the two trials stopped taking SYMTUZA® due to side effects through 11 months.
NO MORE THAN
2%
of patients in any of the 2 trials stopped taking SYMTUZA® due to side effects through 11 months.
There was a low incidence of HIV treatment-related weight gain across both studies through 11 months.
There was a low incidence of HIV treatment-related weight gain across both studies through 11 months.
What are common side effects of SYMTUZA®?
As with most medications, SYMTUZA® can cause side effects. The most common side effects occurring in at least 2% of patients taking SYMTUZA® were:
- Diarrhea
- Bone weakness
- Rash
- Nausea
- Fatigue
- Headache
- Stomach problems
- Gas
These are not all the possible side effects of SYMTUZA®. For more information, please refer to the Important Safety Information, including Boxed Warning, for SYMTUZA® and talk to your doctor.
Is weight gain a concern?
Weight gain can impact an individual's overall health, and it can be a concern when starting a new HIV treatment.*
Certain HIV treatments may cause more weight gain than other treatments. Some individuals can gain more weight on certain treatments than others. Always talk to your doctor before making any changes to your treatment regimen.
0
patients had to stop taking SYMTUZA® due to weight gain in two key studies.†
0
patients had to stop taking SYMTUZA® due to weight gain in two key studies.†
*Long-term consequences of weight gain are not known. As research continues in this area, it's important to have ongoing conversations with your healthcare provider.
†Across 2 clinical trials, one patient taking SYMTUZA® experienced treatment-related weight gain. The average weight gain over 48 weeks was between 3.13 lbs (1.42 kg) and 3.84 lbs (1.75 kg) in 1,125 patients in the SYMTUZA® group, and ~1 lb (.45 kg) for 741 patients in the control group. The long-term impact of SYMTUZA® on weight has not been studied in clinical trials.
This person is not a real SYMTUZA® patient.
Taking SYMTUZA®.
Learn what the treatment plan is like with one pill, once-daily SYMTUZA®.
© Janssen Therapeutics, Division of Janssen Products, LP 2024.
All rights reserved. 06/24 cp-251208v9